Wiskott‐Aldrich syndrome (WAS) is a rare X‐linked primary immunodeficiency characterized
by microthrombocytopenia, eczema, recurrent infections, and an increased incidence of …

The inherited platelet disorders are an uncommon cause of symptomatic bleeding. They
may be difficult to diagnose (and are likely to be under‐diagnosed) and pose problems in …

Summary Background Wiskott-Aldrich syndrome is a rare, life-threatening, X-linked primary
immunodeficiency characterised by microthrombocytopenia, infections, eczema …

The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American
College of Allergy, Asthma & Immunology (ACAAI) have jointly accepted responsibility for …

BACKGROUND: Hematopoietic stem cell transplantation remains the only treatment for most
patients with severe combined immunodeficiencies (SCIDs) or other primary …

The purpose of this Practice Parameter for the Diagnosis and Management of Primary
Immunodeficiency is to provide the consultant allergist/immunologist with a practical guide …

In this retrospective collaborative study, we have analyzed long-term outcome and donor
cell engraftment in 194 patients with Wiskott-Aldrich syndrome (WAS) who have been …

Background Transplantation of allogeneic haemopoietic stem cells can cure several primary
immunodeficiencies. This European report focuses on the long-term results of such …

Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative treatment
for patients affected by Wiskott-Aldrich syndrome (WAS). Reported HSCT outcomes have …

Wiskott-Aldrich syndrome (WAS) is an X-linked disease caused by mutations in the WAS
gene, leading to thrombocytopenia, eczema, recurrent infections, autoimmune disease, and …